Avalon GloboCare Corp. (ALBT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avalon GloboCare Corp. (ALBT) has a cash flow conversion efficiency ratio of -0.264x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.09 Million) by net assets ($11.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Avalon GloboCare Corp. fund operations to measure how many days the company can operate on defensive assets alone.
Avalon GloboCare Corp. - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Avalon GloboCare Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avalon GloboCare Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avalon GloboCare Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Novra Technologies Inc
V:NVI
|
-0.231x |
|
International Biotechnology Trust plc
LSE:IBT
|
0.126x |
|
Raja Ferry Port Public Company Limited
BK:RP
|
0.059x |
|
XP Chemistries AB
ST:XPC
|
-0.113x |
|
BIOVAXYS TECHNOLOGY CORP.
F:5LB
|
N/A |
|
Adeunis
PA:ALARF
|
0.734x |
|
Enrg Elements Ltd
AU:EEL
|
-0.578x |
|
AS Rigas kugu buvetava
STU:UW3
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Avalon GloboCare Corp. (2015–2025)
The table below shows the annual cash flow conversion efficiency of Avalon GloboCare Corp. from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Avalon GloboCare Corp. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $9.23 Million | $-4.99 Million | -0.540x | +22.76% |
| 2024-12-31 | $7.10 Million | $-4.97 Million | -0.700x | +20.74% |
| 2023-12-31 | $7.37 Million | $-6.50 Million | -0.883x | -39.98% |
| 2022-12-31 | $11.16 Million | $-7.04 Million | -0.631x | +61.29% |
| 2021-12-31 | $3.08 Million | $-5.02 Million | -1.629x | +11.13% |
| 2020-12-31 | $4.12 Million | $-7.55 Million | -1.833x | -15.60% |
| 2019-12-31 | $4.47 Million | $-7.08 Million | -1.586x | -305.92% |
| 2018-12-31 | $11.25 Million | $-4.40 Million | -0.391x | -113.11% |
| 2017-12-31 | $7.31 Million | $-1.34 Million | -0.183x | -4748.22% |
| 2016-12-31 | $3.55 Million | $13.98K | 0.004x | -99.93% |
| 2015-12-31 | $-5.41K | $-30.11K | 5.569x | -- |
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI … Read more